Hong Jae Chon, Director of Cancer Center, CHA Bundang Medical Center, shared a post on X:
“Five wishes for the future of HCC care – editorial by Stephen L. Chan, Bruno Sangro and Lorenza Rimassa in Journal of Hepatology!
- Prevention: Global public health framework to eradicate viral hepatitis and tackle lifestyle-related liver disease
- Screening: Annual blood-based biomarker + mobile integration
- Biopsy: Routine histology and sequencing as standard in trials
- Staging: International consensus on resectable vs. unresectable HCC
- VP4: No longer an automatic exclusion from clinical trials”
Title: The hepatocellular carcinoma wish list: Five aspirations for future care
Author: Stephen L. Chan, Bruno Sangro Send, Lorenza Rimassa.
You can also read: ‘EvIDHence Study: Real-World Outcomes in IDH1-Mutant and Wild-Type Cholangiocarcinoma Before mIDH1 Inhibitors‘
